Karma of The Day: Drug Company Steps Up to Screw With Greedy CEO Martin Shkreli
When Martin Shkreli isn't busy jacking up the price of a life-saving cancer and AIDS drug by 5,000 percent or being an idiot on Twitter, the disgraced pharmaceutical CEO is neck deep in sweet Karma.
San Diego-based Imprimis Pharmaceuticals Inc. announced they will sell the same exact drug Shkreli's company Turing Pharmaceuticals does, but for only $1 a pill.
Shkreli charges $750 a pill.
"We are looking at all of these cases where the sole-source generic companies are jacking the price way up," Mark Baum, Chief Executive at Imprimis, told the AP.
"There'll be many more of these."
Meanwhile, Shkreli decided to start a spat with CNBC on Twitter.
CNBC primetime viewership: 226,000. lol. 90% are muted TVs in hedge fund offices.
— Martin Shkreli (@MartinShkreli) October 22, 2015I've decided to unfollow and block @MartinShkreli. He's a no-cred clown who doesn't deserve the attention he seeks. #hack
— Scott Wapner (@ScottWapnerCNBC) October 23, 2015Martin Shkreli, the poor man's Donald Trump.